💎
PharmaDepth
Home
Companies
PDUFA Calendar
FDA Approved Products
Application #
Type
Sponsor
Notes
Product #
Drug Name
Form
Strength
Active Ingredient
Approval Date
Marketing Status
Reference Standard
219301
NDA
KALVISTA
001
EKTERLY
TABLET;ORAL
300MG
SEBETRALSTAT
2025-07-03
Prescription
Yes